Medical Devices & Consumables
Global Molecular Testing for Respiratory Pathogens Market Research Report 2025
- Sep 24, 25
- ID: 523085
- Pages: 103
- Figures: 98
- Views: 7
Report Scope
This report aims to provide a comprehensive presentation of the global market for Molecular Testing for Respiratory Pathogens, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Testing for Respiratory Pathogens.
The Molecular Testing for Respiratory Pathogens market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Testing for Respiratory Pathogens market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Testing for Respiratory Pathogens manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BioFire Diagnostics
DiaSorin
Seegene
Qiagen
Hoffmann-La Roche
Cepheid (Danaher)
Abbott Laboratories
QuidelOrtho
Illumina
ZeptoMetrix
Sansure
BGI Genomics
bioMérieux
AusDiagnostics
Anatolia Geneworks
DaAn Gene
Segment by Type
Single Pathogen Test
Multiple Pathogen Test
Segment by Application
Hospital
Diagnostic Laboratories
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Testing for Respiratory Pathogens manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Testing for Respiratory Pathogens in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Molecular Testing for Respiratory Pathogens, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Testing for Respiratory Pathogens.
The Molecular Testing for Respiratory Pathogens market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Testing for Respiratory Pathogens market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Testing for Respiratory Pathogens manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BioFire Diagnostics
DiaSorin
Seegene
Qiagen
Hoffmann-La Roche
Cepheid (Danaher)
Abbott Laboratories
QuidelOrtho
Illumina
ZeptoMetrix
Sansure
BGI Genomics
bioMérieux
AusDiagnostics
Anatolia Geneworks
DaAn Gene
Segment by Type
Single Pathogen Test
Multiple Pathogen Test
Segment by Application
Hospital
Diagnostic Laboratories
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Testing for Respiratory Pathogens manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Testing for Respiratory Pathogens in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Molecular Testing for Respiratory Pathogens Market Overview
1.1 Product Definition
1.2 Molecular Testing for Respiratory Pathogens by Type
1.2.1 Global Molecular Testing for Respiratory Pathogens Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single Pathogen Test
1.2.3 Multiple Pathogen Test
1.3 Molecular Testing for Respiratory Pathogens by Application
1.3.1 Global Molecular Testing for Respiratory Pathogens Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.4 Global Molecular Testing for Respiratory Pathogens Market Size Estimates and Forecasts
1.4.1 Global Molecular Testing for Respiratory Pathogens Revenue 2020-2031
1.4.2 Global Molecular Testing for Respiratory Pathogens Sales 2020-2031
1.4.3 Global Molecular Testing for Respiratory Pathogens Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Molecular Testing for Respiratory Pathogens Market Competition by Manufacturers
2.1 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Manufacturers (2020-2025)
2.2 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Molecular Testing for Respiratory Pathogens Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Molecular Testing for Respiratory Pathogens, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Product Type & Application
2.7 Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Date of Enter into This Industry
2.8 Global Molecular Testing for Respiratory Pathogens Market Competitive Situation and Trends
2.8.1 Global Molecular Testing for Respiratory Pathogens Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Molecular Testing for Respiratory Pathogens Players Market Share by Revenue
2.8.3 Global Molecular Testing for Respiratory Pathogens Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Molecular Testing for Respiratory Pathogens Market Scenario by Region
3.1 Global Molecular Testing for Respiratory Pathogens Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Molecular Testing for Respiratory Pathogens Sales by Region: 2020-2031
3.2.1 Global Molecular Testing for Respiratory Pathogens Sales by Region: 2020-2025
3.2.2 Global Molecular Testing for Respiratory Pathogens Sales by Region: 2026-2031
3.3 Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2020-2031
3.3.1 Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2020-2025
3.3.2 Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2026-2031
3.4 North America Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.4.1 North America Molecular Testing for Respiratory Pathogens Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Molecular Testing for Respiratory Pathogens Sales by Country (2020-2031)
3.4.3 North America Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.5.1 Europe Molecular Testing for Respiratory Pathogens Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Molecular Testing for Respiratory Pathogens Sales by Country (2020-2031)
3.5.3 Europe Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Testing for Respiratory Pathogens Market Facts & Figures by Region
3.6.1 Asia Pacific Molecular Testing for Respiratory Pathogens Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Molecular Testing for Respiratory Pathogens Sales by Region (2020-2031)
3.6.3 Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.7.1 Latin America Molecular Testing for Respiratory Pathogens Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Molecular Testing for Respiratory Pathogens Sales by Country (2020-2031)
3.7.3 Latin America Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Testing for Respiratory Pathogens Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Molecular Testing for Respiratory Pathogens Sales by Country (2020-2031)
3.8.3 Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Molecular Testing for Respiratory Pathogens Sales by Type (2020-2031)
4.1.1 Global Molecular Testing for Respiratory Pathogens Sales by Type (2020-2025)
4.1.2 Global Molecular Testing for Respiratory Pathogens Sales by Type (2026-2031)
4.1.3 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Type (2020-2031)
4.2 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2020-2031)
4.2.1 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2020-2025)
4.2.2 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2026-2031)
4.2.3 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Type (2020-2031)
4.3 Global Molecular Testing for Respiratory Pathogens Price by Type (2020-2031)
5 Segment by Application
5.1 Global Molecular Testing for Respiratory Pathogens Sales by Application (2020-2031)
5.1.1 Global Molecular Testing for Respiratory Pathogens Sales by Application (2020-2025)
5.1.2 Global Molecular Testing for Respiratory Pathogens Sales by Application (2026-2031)
5.1.3 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Application (2020-2031)
5.2 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2020-2031)
5.2.1 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2020-2025)
5.2.2 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2026-2031)
5.2.3 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Application (2020-2031)
5.3 Global Molecular Testing for Respiratory Pathogens Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BioFire Diagnostics
6.1.1 BioFire Diagnostics Company Information
6.1.2 BioFire Diagnostics Description and Business Overview
6.1.3 BioFire Diagnostics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BioFire Diagnostics Molecular Testing for Respiratory Pathogens Product Portfolio
6.1.5 BioFire Diagnostics Recent Developments/Updates
6.2 DiaSorin
6.2.1 DiaSorin Company Information
6.2.2 DiaSorin Description and Business Overview
6.2.3 DiaSorin Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.2.4 DiaSorin Molecular Testing for Respiratory Pathogens Product Portfolio
6.2.5 DiaSorin Recent Developments/Updates
6.3 Seegene
6.3.1 Seegene Company Information
6.3.2 Seegene Description and Business Overview
6.3.3 Seegene Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Seegene Molecular Testing for Respiratory Pathogens Product Portfolio
6.3.5 Seegene Recent Developments/Updates
6.4 Qiagen
6.4.1 Qiagen Company Information
6.4.2 Qiagen Description and Business Overview
6.4.3 Qiagen Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Qiagen Molecular Testing for Respiratory Pathogens Product Portfolio
6.4.5 Qiagen Recent Developments/Updates
6.5 Hoffmann-La Roche
6.5.1 Hoffmann-La Roche Company Information
6.5.2 Hoffmann-La Roche Description and Business Overview
6.5.3 Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Product Portfolio
6.5.5 Hoffmann-La Roche Recent Developments/Updates
6.6 Cepheid (Danaher)
6.6.1 Cepheid (Danaher) Company Information
6.6.2 Cepheid (Danaher) Description and Business Overview
6.6.3 Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Product Portfolio
6.6.5 Cepheid (Danaher) Recent Developments/Updates
6.7 Abbott Laboratories
6.7.1 Abbott Laboratories Company Information
6.7.2 Abbott Laboratories Description and Business Overview
6.7.3 Abbott Laboratories Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Laboratories Molecular Testing for Respiratory Pathogens Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 QuidelOrtho
6.8.1 QuidelOrtho Company Information
6.8.2 QuidelOrtho Description and Business Overview
6.8.3 QuidelOrtho Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.8.4 QuidelOrtho Molecular Testing for Respiratory Pathogens Product Portfolio
6.8.5 QuidelOrtho Recent Developments/Updates
6.9 Illumina
6.9.1 Illumina Company Information
6.9.2 Illumina Description and Business Overview
6.9.3 Illumina Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Illumina Molecular Testing for Respiratory Pathogens Product Portfolio
6.9.5 Illumina Recent Developments/Updates
6.10 ZeptoMetrix
6.10.1 ZeptoMetrix Company Information
6.10.2 ZeptoMetrix Description and Business Overview
6.10.3 ZeptoMetrix Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ZeptoMetrix Molecular Testing for Respiratory Pathogens Product Portfolio
6.10.5 ZeptoMetrix Recent Developments/Updates
6.11 Sansure
6.11.1 Sansure Company Information
6.11.2 Sansure Description and Business Overview
6.11.3 Sansure Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sansure Molecular Testing for Respiratory Pathogens Product Portfolio
6.11.5 Sansure Recent Developments/Updates
6.12 BGI Genomics
6.12.1 BGI Genomics Company Information
6.12.2 BGI Genomics Description and Business Overview
6.12.3 BGI Genomics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BGI Genomics Molecular Testing for Respiratory Pathogens Product Portfolio
6.12.5 BGI Genomics Recent Developments/Updates
6.13 bioMérieux
6.13.1 bioMérieux Company Information
6.13.2 bioMérieux Description and Business Overview
6.13.3 bioMérieux Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.13.4 bioMérieux Molecular Testing for Respiratory Pathogens Product Portfolio
6.13.5 bioMérieux Recent Developments/Updates
6.14 AusDiagnostics
6.14.1 AusDiagnostics Company Information
6.14.2 AusDiagnostics Description and Business Overview
6.14.3 AusDiagnostics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.14.4 AusDiagnostics Molecular Testing for Respiratory Pathogens Product Portfolio
6.14.5 AusDiagnostics Recent Developments/Updates
6.15 Anatolia Geneworks
6.15.1 Anatolia Geneworks Company Information
6.15.2 Anatolia Geneworks Description and Business Overview
6.15.3 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Product Portfolio
6.15.5 Anatolia Geneworks Recent Developments/Updates
6.16 DaAn Gene
6.16.1 DaAn Gene Company Information
6.16.2 DaAn Gene Description and Business Overview
6.16.3 DaAn Gene Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.16.4 DaAn Gene Molecular Testing for Respiratory Pathogens Product Portfolio
6.16.5 DaAn Gene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Testing for Respiratory Pathogens Industry Chain Analysis
7.2 Molecular Testing for Respiratory Pathogens Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Testing for Respiratory Pathogens Production Mode & Process Analysis
7.4 Molecular Testing for Respiratory Pathogens Sales and Marketing
7.4.1 Molecular Testing for Respiratory Pathogens Sales Channels
7.4.2 Molecular Testing for Respiratory Pathogens Distributors
7.5 Molecular Testing for Respiratory Pathogens Customer Analysis
8 Molecular Testing for Respiratory Pathogens Market Dynamics
8.1 Molecular Testing for Respiratory Pathogens Industry Trends
8.2 Molecular Testing for Respiratory Pathogens Market Drivers
8.3 Molecular Testing for Respiratory Pathogens Market Challenges
8.4 Molecular Testing for Respiratory Pathogens Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Molecular Testing for Respiratory Pathogens by Type
1.2.1 Global Molecular Testing for Respiratory Pathogens Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single Pathogen Test
1.2.3 Multiple Pathogen Test
1.3 Molecular Testing for Respiratory Pathogens by Application
1.3.1 Global Molecular Testing for Respiratory Pathogens Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.4 Global Molecular Testing for Respiratory Pathogens Market Size Estimates and Forecasts
1.4.1 Global Molecular Testing for Respiratory Pathogens Revenue 2020-2031
1.4.2 Global Molecular Testing for Respiratory Pathogens Sales 2020-2031
1.4.3 Global Molecular Testing for Respiratory Pathogens Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Molecular Testing for Respiratory Pathogens Market Competition by Manufacturers
2.1 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Manufacturers (2020-2025)
2.2 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Molecular Testing for Respiratory Pathogens Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Molecular Testing for Respiratory Pathogens, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Product Type & Application
2.7 Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Date of Enter into This Industry
2.8 Global Molecular Testing for Respiratory Pathogens Market Competitive Situation and Trends
2.8.1 Global Molecular Testing for Respiratory Pathogens Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Molecular Testing for Respiratory Pathogens Players Market Share by Revenue
2.8.3 Global Molecular Testing for Respiratory Pathogens Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Molecular Testing for Respiratory Pathogens Market Scenario by Region
3.1 Global Molecular Testing for Respiratory Pathogens Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Molecular Testing for Respiratory Pathogens Sales by Region: 2020-2031
3.2.1 Global Molecular Testing for Respiratory Pathogens Sales by Region: 2020-2025
3.2.2 Global Molecular Testing for Respiratory Pathogens Sales by Region: 2026-2031
3.3 Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2020-2031
3.3.1 Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2020-2025
3.3.2 Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2026-2031
3.4 North America Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.4.1 North America Molecular Testing for Respiratory Pathogens Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Molecular Testing for Respiratory Pathogens Sales by Country (2020-2031)
3.4.3 North America Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.5.1 Europe Molecular Testing for Respiratory Pathogens Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Molecular Testing for Respiratory Pathogens Sales by Country (2020-2031)
3.5.3 Europe Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Testing for Respiratory Pathogens Market Facts & Figures by Region
3.6.1 Asia Pacific Molecular Testing for Respiratory Pathogens Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Molecular Testing for Respiratory Pathogens Sales by Region (2020-2031)
3.6.3 Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.7.1 Latin America Molecular Testing for Respiratory Pathogens Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Molecular Testing for Respiratory Pathogens Sales by Country (2020-2031)
3.7.3 Latin America Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Testing for Respiratory Pathogens Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Molecular Testing for Respiratory Pathogens Sales by Country (2020-2031)
3.8.3 Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Molecular Testing for Respiratory Pathogens Sales by Type (2020-2031)
4.1.1 Global Molecular Testing for Respiratory Pathogens Sales by Type (2020-2025)
4.1.2 Global Molecular Testing for Respiratory Pathogens Sales by Type (2026-2031)
4.1.3 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Type (2020-2031)
4.2 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2020-2031)
4.2.1 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2020-2025)
4.2.2 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2026-2031)
4.2.3 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Type (2020-2031)
4.3 Global Molecular Testing for Respiratory Pathogens Price by Type (2020-2031)
5 Segment by Application
5.1 Global Molecular Testing for Respiratory Pathogens Sales by Application (2020-2031)
5.1.1 Global Molecular Testing for Respiratory Pathogens Sales by Application (2020-2025)
5.1.2 Global Molecular Testing for Respiratory Pathogens Sales by Application (2026-2031)
5.1.3 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Application (2020-2031)
5.2 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2020-2031)
5.2.1 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2020-2025)
5.2.2 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2026-2031)
5.2.3 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Application (2020-2031)
5.3 Global Molecular Testing for Respiratory Pathogens Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BioFire Diagnostics
6.1.1 BioFire Diagnostics Company Information
6.1.2 BioFire Diagnostics Description and Business Overview
6.1.3 BioFire Diagnostics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BioFire Diagnostics Molecular Testing for Respiratory Pathogens Product Portfolio
6.1.5 BioFire Diagnostics Recent Developments/Updates
6.2 DiaSorin
6.2.1 DiaSorin Company Information
6.2.2 DiaSorin Description and Business Overview
6.2.3 DiaSorin Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.2.4 DiaSorin Molecular Testing for Respiratory Pathogens Product Portfolio
6.2.5 DiaSorin Recent Developments/Updates
6.3 Seegene
6.3.1 Seegene Company Information
6.3.2 Seegene Description and Business Overview
6.3.3 Seegene Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Seegene Molecular Testing for Respiratory Pathogens Product Portfolio
6.3.5 Seegene Recent Developments/Updates
6.4 Qiagen
6.4.1 Qiagen Company Information
6.4.2 Qiagen Description and Business Overview
6.4.3 Qiagen Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Qiagen Molecular Testing for Respiratory Pathogens Product Portfolio
6.4.5 Qiagen Recent Developments/Updates
6.5 Hoffmann-La Roche
6.5.1 Hoffmann-La Roche Company Information
6.5.2 Hoffmann-La Roche Description and Business Overview
6.5.3 Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Product Portfolio
6.5.5 Hoffmann-La Roche Recent Developments/Updates
6.6 Cepheid (Danaher)
6.6.1 Cepheid (Danaher) Company Information
6.6.2 Cepheid (Danaher) Description and Business Overview
6.6.3 Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Product Portfolio
6.6.5 Cepheid (Danaher) Recent Developments/Updates
6.7 Abbott Laboratories
6.7.1 Abbott Laboratories Company Information
6.7.2 Abbott Laboratories Description and Business Overview
6.7.3 Abbott Laboratories Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Laboratories Molecular Testing for Respiratory Pathogens Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 QuidelOrtho
6.8.1 QuidelOrtho Company Information
6.8.2 QuidelOrtho Description and Business Overview
6.8.3 QuidelOrtho Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.8.4 QuidelOrtho Molecular Testing for Respiratory Pathogens Product Portfolio
6.8.5 QuidelOrtho Recent Developments/Updates
6.9 Illumina
6.9.1 Illumina Company Information
6.9.2 Illumina Description and Business Overview
6.9.3 Illumina Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Illumina Molecular Testing for Respiratory Pathogens Product Portfolio
6.9.5 Illumina Recent Developments/Updates
6.10 ZeptoMetrix
6.10.1 ZeptoMetrix Company Information
6.10.2 ZeptoMetrix Description and Business Overview
6.10.3 ZeptoMetrix Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ZeptoMetrix Molecular Testing for Respiratory Pathogens Product Portfolio
6.10.5 ZeptoMetrix Recent Developments/Updates
6.11 Sansure
6.11.1 Sansure Company Information
6.11.2 Sansure Description and Business Overview
6.11.3 Sansure Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sansure Molecular Testing for Respiratory Pathogens Product Portfolio
6.11.5 Sansure Recent Developments/Updates
6.12 BGI Genomics
6.12.1 BGI Genomics Company Information
6.12.2 BGI Genomics Description and Business Overview
6.12.3 BGI Genomics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BGI Genomics Molecular Testing for Respiratory Pathogens Product Portfolio
6.12.5 BGI Genomics Recent Developments/Updates
6.13 bioMérieux
6.13.1 bioMérieux Company Information
6.13.2 bioMérieux Description and Business Overview
6.13.3 bioMérieux Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.13.4 bioMérieux Molecular Testing for Respiratory Pathogens Product Portfolio
6.13.5 bioMérieux Recent Developments/Updates
6.14 AusDiagnostics
6.14.1 AusDiagnostics Company Information
6.14.2 AusDiagnostics Description and Business Overview
6.14.3 AusDiagnostics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.14.4 AusDiagnostics Molecular Testing for Respiratory Pathogens Product Portfolio
6.14.5 AusDiagnostics Recent Developments/Updates
6.15 Anatolia Geneworks
6.15.1 Anatolia Geneworks Company Information
6.15.2 Anatolia Geneworks Description and Business Overview
6.15.3 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Product Portfolio
6.15.5 Anatolia Geneworks Recent Developments/Updates
6.16 DaAn Gene
6.16.1 DaAn Gene Company Information
6.16.2 DaAn Gene Description and Business Overview
6.16.3 DaAn Gene Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2020-2025)
6.16.4 DaAn Gene Molecular Testing for Respiratory Pathogens Product Portfolio
6.16.5 DaAn Gene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Testing for Respiratory Pathogens Industry Chain Analysis
7.2 Molecular Testing for Respiratory Pathogens Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Testing for Respiratory Pathogens Production Mode & Process Analysis
7.4 Molecular Testing for Respiratory Pathogens Sales and Marketing
7.4.1 Molecular Testing for Respiratory Pathogens Sales Channels
7.4.2 Molecular Testing for Respiratory Pathogens Distributors
7.5 Molecular Testing for Respiratory Pathogens Customer Analysis
8 Molecular Testing for Respiratory Pathogens Market Dynamics
8.1 Molecular Testing for Respiratory Pathogens Industry Trends
8.2 Molecular Testing for Respiratory Pathogens Market Drivers
8.3 Molecular Testing for Respiratory Pathogens Market Challenges
8.4 Molecular Testing for Respiratory Pathogens Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Molecular Testing for Respiratory Pathogens Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Molecular Testing for Respiratory Pathogens Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Molecular Testing for Respiratory Pathogens Market Competitive Situation by Manufacturers in 2024
Table 4. Global Molecular Testing for Respiratory Pathogens Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Molecular Testing for Respiratory Pathogens Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Molecular Testing for Respiratory Pathogens Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Molecular Testing for Respiratory Pathogens, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Product Type & Application
Table 12. Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Testing for Respiratory Pathogens by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Testing for Respiratory Pathogens as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Molecular Testing for Respiratory Pathogens Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Molecular Testing for Respiratory Pathogens Sales by Region (2020-2025) & (K Units)
Table 18. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Region (2020-2025)
Table 19. Global Molecular Testing for Respiratory Pathogens Sales by Region (2026-2031) & (K Units)
Table 20. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Region (2026-2031)
Table 21. Global Molecular Testing for Respiratory Pathogens Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Region (2020-2025)
Table 23. Global Molecular Testing for Respiratory Pathogens Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Region (2026-2031)
Table 25. North America Molecular Testing for Respiratory Pathogens Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Molecular Testing for Respiratory Pathogens Sales by Country (2020-2025) & (K Units)
Table 27. North America Molecular Testing for Respiratory Pathogens Sales by Country (2026-2031) & (K Units)
Table 28. North America Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Molecular Testing for Respiratory Pathogens Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Molecular Testing for Respiratory Pathogens Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Molecular Testing for Respiratory Pathogens Sales by Country (2020-2025) & (K Units)
Table 32. Europe Molecular Testing for Respiratory Pathogens Sales by Country (2026-2031) & (K Units)
Table 33. Europe Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Molecular Testing for Respiratory Pathogens Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Molecular Testing for Respiratory Pathogens Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Molecular Testing for Respiratory Pathogens Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Molecular Testing for Respiratory Pathogens Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Molecular Testing for Respiratory Pathogens Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Molecular Testing for Respiratory Pathogens Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Testing for Respiratory Pathogens Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Molecular Testing for Respiratory Pathogens Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Molecular Testing for Respiratory Pathogens Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Molecular Testing for Respiratory Pathogens Sales (K Units) by Type (2020-2025)
Table 51. Global Molecular Testing for Respiratory Pathogens Sales (K Units) by Type (2026-2031)
Table 52. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Type (2020-2025)
Table 53. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Type (2026-2031)
Table 54. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Type (2020-2025)
Table 57. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Type (2026-2031)
Table 58. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Type (2020-2025)
Table 59. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Type (2026-2031)
Table 60. Global Molecular Testing for Respiratory Pathogens Sales (K Units) by Application (2020-2025)
Table 61. Global Molecular Testing for Respiratory Pathogens Sales (K Units) by Application (2026-2031)
Table 62. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Application (2020-2025)
Table 63. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Application (2026-2031)
Table 64. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Application (2020-2025)
Table 67. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Application (2026-2031)
Table 68. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Application (2020-2025)
Table 69. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Application (2026-2031)
Table 70. BioFire Diagnostics Company Information
Table 71. BioFire Diagnostics Description and Business Overview
Table 72. BioFire Diagnostics Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. BioFire Diagnostics Molecular Testing for Respiratory Pathogens Product
Table 74. BioFire Diagnostics Recent Developments/Updates
Table 75. DiaSorin Company Information
Table 76. DiaSorin Description and Business Overview
Table 77. DiaSorin Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. DiaSorin Molecular Testing for Respiratory Pathogens Product
Table 79. DiaSorin Recent Developments/Updates
Table 80. Seegene Company Information
Table 81. Seegene Description and Business Overview
Table 82. Seegene Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Seegene Molecular Testing for Respiratory Pathogens Product
Table 84. Seegene Recent Developments/Updates
Table 85. Qiagen Company Information
Table 86. Qiagen Description and Business Overview
Table 87. Qiagen Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Qiagen Molecular Testing for Respiratory Pathogens Product
Table 89. Qiagen Recent Developments/Updates
Table 90. Hoffmann-La Roche Company Information
Table 91. Hoffmann-La Roche Description and Business Overview
Table 92. Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Product
Table 94. Hoffmann-La Roche Recent Developments/Updates
Table 95. Cepheid (Danaher) Company Information
Table 96. Cepheid (Danaher) Description and Business Overview
Table 97. Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Product
Table 99. Cepheid (Danaher) Recent Developments/Updates
Table 100. Abbott Laboratories Company Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Laboratories Molecular Testing for Respiratory Pathogens Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. QuidelOrtho Company Information
Table 106. QuidelOrtho Description and Business Overview
Table 107. QuidelOrtho Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. QuidelOrtho Molecular Testing for Respiratory Pathogens Product
Table 109. QuidelOrtho Recent Developments/Updates
Table 110. Illumina Company Information
Table 111. Illumina Description and Business Overview
Table 112. Illumina Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Illumina Molecular Testing for Respiratory Pathogens Product
Table 114. Illumina Recent Developments/Updates
Table 115. ZeptoMetrix Company Information
Table 116. ZeptoMetrix Description and Business Overview
Table 117. ZeptoMetrix Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. ZeptoMetrix Molecular Testing for Respiratory Pathogens Product
Table 119. ZeptoMetrix Recent Developments/Updates
Table 120. Sansure Company Information
Table 121. Sansure Description and Business Overview
Table 122. Sansure Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sansure Molecular Testing for Respiratory Pathogens Product
Table 124. Sansure Recent Developments/Updates
Table 125. BGI Genomics Company Information
Table 126. BGI Genomics Description and Business Overview
Table 127. BGI Genomics Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. BGI Genomics Molecular Testing for Respiratory Pathogens Product
Table 129. BGI Genomics Recent Developments/Updates
Table 130. bioMérieux Company Information
Table 131. bioMérieux Description and Business Overview
Table 132. bioMérieux Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. bioMérieux Molecular Testing for Respiratory Pathogens Product
Table 134. bioMérieux Recent Developments/Updates
Table 135. AusDiagnostics Company Information
Table 136. AusDiagnostics Description and Business Overview
Table 137. AusDiagnostics Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. AusDiagnostics Molecular Testing for Respiratory Pathogens Product
Table 139. AusDiagnostics Recent Developments/Updates
Table 140. Anatolia Geneworks Company Information
Table 141. Anatolia Geneworks Description and Business Overview
Table 142. Anatolia Geneworks Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Anatolia Geneworks Molecular Testing for Respiratory Pathogens Product
Table 144. Anatolia Geneworks Recent Developments/Updates
Table 145. DaAn Gene Company Information
Table 146. DaAn Gene Description and Business Overview
Table 147. DaAn Gene Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. DaAn Gene Molecular Testing for Respiratory Pathogens Product
Table 149. DaAn Gene Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Molecular Testing for Respiratory Pathogens Distributors List
Table 153. Molecular Testing for Respiratory Pathogens Customers List
Table 154. Molecular Testing for Respiratory Pathogens Market Trends
Table 155. Molecular Testing for Respiratory Pathogens Market Drivers
Table 156. Molecular Testing for Respiratory Pathogens Market Challenges
Table 157. Molecular Testing for Respiratory Pathogens Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Molecular Testing for Respiratory Pathogens
Figure 2. Global Molecular Testing for Respiratory Pathogens Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Testing for Respiratory Pathogens Market Share by Type: 2024 & 2031
Figure 4. Single Pathogen Test Product Picture
Figure 5. Multiple Pathogen Test Product Picture
Figure 6. Global Molecular Testing for Respiratory Pathogens Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Molecular Testing for Respiratory Pathogens Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Diagnostic Laboratories
Figure 10. Global Molecular Testing for Respiratory Pathogens Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Molecular Testing for Respiratory Pathogens Market Size (2020-2031) & (US$ Million)
Figure 12. Global Molecular Testing for Respiratory Pathogens Sales (2020-2031) & (K Units)
Figure 13. Global Molecular Testing for Respiratory Pathogens Average Price (US$/Unit) & (2020-2031)
Figure 14. Molecular Testing for Respiratory Pathogens Report Years Considered
Figure 15. Molecular Testing for Respiratory Pathogens Sales Share by Manufacturers in 2024
Figure 16. Global Molecular Testing for Respiratory Pathogens Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Molecular Testing for Respiratory Pathogens Players: Market Share by Revenue in Molecular Testing for Respiratory Pathogens in 2024
Figure 18. Molecular Testing for Respiratory Pathogens Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Molecular Testing for Respiratory Pathogens Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Molecular Testing for Respiratory Pathogens Sales Market Share by Country (2020-2031)
Figure 21. North America Molecular Testing for Respiratory Pathogens Revenue Market Share by Country (2020-2031)
Figure 22. United States Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Molecular Testing for Respiratory Pathogens Sales Market Share by Country (2020-2031)
Figure 25. Europe Molecular Testing for Respiratory Pathogens Revenue Market Share by Country (2020-2031)
Figure 26. Germany Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Molecular Testing for Respiratory Pathogens Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Molecular Testing for Respiratory Pathogens Revenue Market Share by Region (2020-2031)
Figure 33. China Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Molecular Testing for Respiratory Pathogens Sales Market Share by Country (2020-2031)
Figure 41. Latin America Molecular Testing for Respiratory Pathogens Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Molecular Testing for Respiratory Pathogens Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Molecular Testing for Respiratory Pathogens by Type (2020-2031)
Figure 51. Global Revenue Market Share of Molecular Testing for Respiratory Pathogens by Type (2020-2031)
Figure 52. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Molecular Testing for Respiratory Pathogens by Application (2020-2031)
Figure 54. Global Revenue Market Share of Molecular Testing for Respiratory Pathogens by Application (2020-2031)
Figure 55. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Application (2020-2031)
Figure 56. Molecular Testing for Respiratory Pathogens Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Molecular Testing for Respiratory Pathogens Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Molecular Testing for Respiratory Pathogens Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Molecular Testing for Respiratory Pathogens Market Competitive Situation by Manufacturers in 2024
Table 4. Global Molecular Testing for Respiratory Pathogens Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Molecular Testing for Respiratory Pathogens Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Molecular Testing for Respiratory Pathogens Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Molecular Testing for Respiratory Pathogens, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Product Type & Application
Table 12. Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Testing for Respiratory Pathogens by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Testing for Respiratory Pathogens as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Molecular Testing for Respiratory Pathogens Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Molecular Testing for Respiratory Pathogens Sales by Region (2020-2025) & (K Units)
Table 18. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Region (2020-2025)
Table 19. Global Molecular Testing for Respiratory Pathogens Sales by Region (2026-2031) & (K Units)
Table 20. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Region (2026-2031)
Table 21. Global Molecular Testing for Respiratory Pathogens Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Region (2020-2025)
Table 23. Global Molecular Testing for Respiratory Pathogens Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Region (2026-2031)
Table 25. North America Molecular Testing for Respiratory Pathogens Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Molecular Testing for Respiratory Pathogens Sales by Country (2020-2025) & (K Units)
Table 27. North America Molecular Testing for Respiratory Pathogens Sales by Country (2026-2031) & (K Units)
Table 28. North America Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Molecular Testing for Respiratory Pathogens Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Molecular Testing for Respiratory Pathogens Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Molecular Testing for Respiratory Pathogens Sales by Country (2020-2025) & (K Units)
Table 32. Europe Molecular Testing for Respiratory Pathogens Sales by Country (2026-2031) & (K Units)
Table 33. Europe Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Molecular Testing for Respiratory Pathogens Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Molecular Testing for Respiratory Pathogens Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Molecular Testing for Respiratory Pathogens Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Molecular Testing for Respiratory Pathogens Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Molecular Testing for Respiratory Pathogens Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Molecular Testing for Respiratory Pathogens Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Testing for Respiratory Pathogens Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Molecular Testing for Respiratory Pathogens Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Molecular Testing for Respiratory Pathogens Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Molecular Testing for Respiratory Pathogens Sales (K Units) by Type (2020-2025)
Table 51. Global Molecular Testing for Respiratory Pathogens Sales (K Units) by Type (2026-2031)
Table 52. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Type (2020-2025)
Table 53. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Type (2026-2031)
Table 54. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Type (2020-2025)
Table 57. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Type (2026-2031)
Table 58. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Type (2020-2025)
Table 59. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Type (2026-2031)
Table 60. Global Molecular Testing for Respiratory Pathogens Sales (K Units) by Application (2020-2025)
Table 61. Global Molecular Testing for Respiratory Pathogens Sales (K Units) by Application (2026-2031)
Table 62. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Application (2020-2025)
Table 63. Global Molecular Testing for Respiratory Pathogens Sales Market Share by Application (2026-2031)
Table 64. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Molecular Testing for Respiratory Pathogens Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Application (2020-2025)
Table 67. Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Application (2026-2031)
Table 68. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Application (2020-2025)
Table 69. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Application (2026-2031)
Table 70. BioFire Diagnostics Company Information
Table 71. BioFire Diagnostics Description and Business Overview
Table 72. BioFire Diagnostics Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. BioFire Diagnostics Molecular Testing for Respiratory Pathogens Product
Table 74. BioFire Diagnostics Recent Developments/Updates
Table 75. DiaSorin Company Information
Table 76. DiaSorin Description and Business Overview
Table 77. DiaSorin Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. DiaSorin Molecular Testing for Respiratory Pathogens Product
Table 79. DiaSorin Recent Developments/Updates
Table 80. Seegene Company Information
Table 81. Seegene Description and Business Overview
Table 82. Seegene Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Seegene Molecular Testing for Respiratory Pathogens Product
Table 84. Seegene Recent Developments/Updates
Table 85. Qiagen Company Information
Table 86. Qiagen Description and Business Overview
Table 87. Qiagen Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Qiagen Molecular Testing for Respiratory Pathogens Product
Table 89. Qiagen Recent Developments/Updates
Table 90. Hoffmann-La Roche Company Information
Table 91. Hoffmann-La Roche Description and Business Overview
Table 92. Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Product
Table 94. Hoffmann-La Roche Recent Developments/Updates
Table 95. Cepheid (Danaher) Company Information
Table 96. Cepheid (Danaher) Description and Business Overview
Table 97. Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Product
Table 99. Cepheid (Danaher) Recent Developments/Updates
Table 100. Abbott Laboratories Company Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Laboratories Molecular Testing for Respiratory Pathogens Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. QuidelOrtho Company Information
Table 106. QuidelOrtho Description and Business Overview
Table 107. QuidelOrtho Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. QuidelOrtho Molecular Testing for Respiratory Pathogens Product
Table 109. QuidelOrtho Recent Developments/Updates
Table 110. Illumina Company Information
Table 111. Illumina Description and Business Overview
Table 112. Illumina Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Illumina Molecular Testing for Respiratory Pathogens Product
Table 114. Illumina Recent Developments/Updates
Table 115. ZeptoMetrix Company Information
Table 116. ZeptoMetrix Description and Business Overview
Table 117. ZeptoMetrix Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. ZeptoMetrix Molecular Testing for Respiratory Pathogens Product
Table 119. ZeptoMetrix Recent Developments/Updates
Table 120. Sansure Company Information
Table 121. Sansure Description and Business Overview
Table 122. Sansure Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sansure Molecular Testing for Respiratory Pathogens Product
Table 124. Sansure Recent Developments/Updates
Table 125. BGI Genomics Company Information
Table 126. BGI Genomics Description and Business Overview
Table 127. BGI Genomics Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. BGI Genomics Molecular Testing for Respiratory Pathogens Product
Table 129. BGI Genomics Recent Developments/Updates
Table 130. bioMérieux Company Information
Table 131. bioMérieux Description and Business Overview
Table 132. bioMérieux Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. bioMérieux Molecular Testing for Respiratory Pathogens Product
Table 134. bioMérieux Recent Developments/Updates
Table 135. AusDiagnostics Company Information
Table 136. AusDiagnostics Description and Business Overview
Table 137. AusDiagnostics Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. AusDiagnostics Molecular Testing for Respiratory Pathogens Product
Table 139. AusDiagnostics Recent Developments/Updates
Table 140. Anatolia Geneworks Company Information
Table 141. Anatolia Geneworks Description and Business Overview
Table 142. Anatolia Geneworks Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Anatolia Geneworks Molecular Testing for Respiratory Pathogens Product
Table 144. Anatolia Geneworks Recent Developments/Updates
Table 145. DaAn Gene Company Information
Table 146. DaAn Gene Description and Business Overview
Table 147. DaAn Gene Molecular Testing for Respiratory Pathogens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. DaAn Gene Molecular Testing for Respiratory Pathogens Product
Table 149. DaAn Gene Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Molecular Testing for Respiratory Pathogens Distributors List
Table 153. Molecular Testing for Respiratory Pathogens Customers List
Table 154. Molecular Testing for Respiratory Pathogens Market Trends
Table 155. Molecular Testing for Respiratory Pathogens Market Drivers
Table 156. Molecular Testing for Respiratory Pathogens Market Challenges
Table 157. Molecular Testing for Respiratory Pathogens Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Molecular Testing for Respiratory Pathogens
Figure 2. Global Molecular Testing for Respiratory Pathogens Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Testing for Respiratory Pathogens Market Share by Type: 2024 & 2031
Figure 4. Single Pathogen Test Product Picture
Figure 5. Multiple Pathogen Test Product Picture
Figure 6. Global Molecular Testing for Respiratory Pathogens Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Molecular Testing for Respiratory Pathogens Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Diagnostic Laboratories
Figure 10. Global Molecular Testing for Respiratory Pathogens Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Molecular Testing for Respiratory Pathogens Market Size (2020-2031) & (US$ Million)
Figure 12. Global Molecular Testing for Respiratory Pathogens Sales (2020-2031) & (K Units)
Figure 13. Global Molecular Testing for Respiratory Pathogens Average Price (US$/Unit) & (2020-2031)
Figure 14. Molecular Testing for Respiratory Pathogens Report Years Considered
Figure 15. Molecular Testing for Respiratory Pathogens Sales Share by Manufacturers in 2024
Figure 16. Global Molecular Testing for Respiratory Pathogens Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Molecular Testing for Respiratory Pathogens Players: Market Share by Revenue in Molecular Testing for Respiratory Pathogens in 2024
Figure 18. Molecular Testing for Respiratory Pathogens Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Molecular Testing for Respiratory Pathogens Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Molecular Testing for Respiratory Pathogens Sales Market Share by Country (2020-2031)
Figure 21. North America Molecular Testing for Respiratory Pathogens Revenue Market Share by Country (2020-2031)
Figure 22. United States Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Molecular Testing for Respiratory Pathogens Sales Market Share by Country (2020-2031)
Figure 25. Europe Molecular Testing for Respiratory Pathogens Revenue Market Share by Country (2020-2031)
Figure 26. Germany Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Molecular Testing for Respiratory Pathogens Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Molecular Testing for Respiratory Pathogens Revenue Market Share by Region (2020-2031)
Figure 33. China Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Molecular Testing for Respiratory Pathogens Sales Market Share by Country (2020-2031)
Figure 41. Latin America Molecular Testing for Respiratory Pathogens Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Molecular Testing for Respiratory Pathogens Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Molecular Testing for Respiratory Pathogens Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Molecular Testing for Respiratory Pathogens by Type (2020-2031)
Figure 51. Global Revenue Market Share of Molecular Testing for Respiratory Pathogens by Type (2020-2031)
Figure 52. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Molecular Testing for Respiratory Pathogens by Application (2020-2031)
Figure 54. Global Revenue Market Share of Molecular Testing for Respiratory Pathogens by Application (2020-2031)
Figure 55. Global Molecular Testing for Respiratory Pathogens Price (US$/Unit) by Application (2020-2031)
Figure 56. Molecular Testing for Respiratory Pathogens Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232